Deceptive Inquiries Made to Drug Information Departments

  • Charles F. Curran


Acute concern is created among drug information department staff in pharmaceutical firms whenever calls are received from individuals who seem deceitful. This paper lists some of the identifying characteristics of these calls, discusses the hazards involved in responding to these callers, and differentiates these calls from those by health care professionals who received disinformation. Measures are suggested to minimize the impact of deceptive callers.

Key Words

Drug information Drug inquiries Deception 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Bowen E. The House in Paris. Part I, Chap. 5. New York, NY: Alfred A. Knopf;1935:55.Google Scholar
  2. 2.
    Radice B, advisory ed. Cicero: Selected Works. VI. Test Cases in Business. New York, NY: Penguin Books; 1971:177–181.Google Scholar
  3. 3.
    Johnson S. The Idler, Number 80. 1758. In: Curwen HD, (ed. A Johnson Sampler. Cambridge, MA: Harvard University Press; 1963:120.Google Scholar

Copyright information

© Drug Information Association, Inc 2002

Authors and Affiliations

  • Charles F. Curran
    • 1
  1. 1.Forest Pharmaceuticals, Inc.St. LouisUSA

Personalised recommendations